Titre : | Final Outcomes Report |
Titre de série : | The Drug Treatment Outcomes Research Study (DTORS) |
Auteurs : | A. JONES ; M. DONMALL ; T. MILLAR ; A. MOODY ; S. WESTON ; T. ANDERSON ; GITTINS M. ; V. ABEYWARDANA ; J. D'SOUZA |
Type de document : | Rapport |
Mention d'édition : | Research Report 24 |
Editeur : | London : Home Office, 2009 |
ISBN/ISSN/EAN : | 978-1-84987-123-5 |
Format : | 58 p. |
Langues: | Anglais |
Discipline : | TRA (Traitement et prise en charge / Treatment and care) |
Mots-clés : |
Thésaurus mots-clés EVALUATION ; TRAITEMENT ; ETUDE LONGITUDINALE ; CRIMINALITE ; DELIT ; JUSTICE ; PREVALENCE ; EFFICACITEThésaurus géographique ROYAUME-UNI |
Résumé : | This report summarises follow-up data from the Drug Treatment Outcomes Research Study (DTORS): a longitudinal study that explores the outcomes of drug treatment in England. The overriding finding is that treatment reduces the harmful behaviours that are associated with problem drug use. The majority of treatment seekers received care-coordinated treatment, expressed satisfaction with their care, were retained in treatment beyond three months, reported significant and substantial reductions in drug use and offending, and improvements in mental well-being and social functioning. DTORS has measured a broad range of outcomes. Where comparable, the positive DTORS outcomes are equivalent to, or better than, those observed a decade ago by NTORS, the previous national outcomes study. Alongside the fact that the number of people in contact with treatment services has more than doubled over the last decade, this suggests that the drug-treatment system has been responding effectively by increasing numbers in treatment and improving treatment effectiveness. Most improvements occur within the first few months of entering treatment. The changes in behaviour observed at first follow-up (three to five months after initial interview) are mainly only sustained at second follow-up (11 to13 months), although there are some additional improvements during this later stage of treatment. This may suggest that there are opportunities to further capitalise on the early gains that are achieved. Further work is needed to establish whether these gains are sustained once treatment has stopped. Levels of drug use declined rapidly within the first three months of starting treatment, and then continued at the same rate, for up to six months. These findings support the validity of the national performance indicator of retention in treatment for at least three months, but suggest potential value in longer measures of retention than currently employed as well as the need for treatment facilities to focus on a continuing process of change. (Author' s abstract) |
Domaine : | Drogues illicites / Illicit drugs |
Affiliation : | Royaume-Uni. United Kingdom. |
Centre Emetteur : | 13 OFDT |
Cote : | E00768-3 |
Lien : | http://www.dtors.org.uk/ |
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Accueil